**Matthew Snelson**

Latest

• Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
• Renal ACE2 (Angiotensin-Converting Enzyme 2) Expression Is Modulated by Dietary Fiber Intake, Gut Microbiota, and Their Metabolites
• Processed foods drive intestinal barrier permeability and microvascular diseases
• Long term high protein diet feeding alters the microbiome and increases intestinal permeability, systemic inflammation and kidney injury in mice
• Gut microbiome, prebiotics, intestinal permeability and diabetes complications
• Targeted deletion of NADPH-Oxidase Nox4 from proximal tubules is dispensable for diabetic kidney disease development
• Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications
• Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease
• Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy
• A Renal Clinician's Guide to the Gut Microbiota
• Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D
• Complement C5a Induces Renal Injury in Diabetic Kidney Disease Via Disruption in Mitochondrial Metabolic Agility
• The Devil's in the Detail: The Importance of Specific, Descriptive Language for Reproducibility in Nutrition Science
• Metabolic effects of resistant starch type 2: a systematic literature review and meta-analysis of randomised controlled trials
• Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology
• Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights
• Differential Effects of High-Protein Diets Derived from Soy and Casein on Blood–Brain Barrier Integrity in Wild-type Mice
• Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD?